BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

680 related articles for article (PubMed ID: 7486540)

  • 1. Analysis of V kappa I and V lambda II light chain genes in the expressed B-cell repertoire.
    Manheimer-Lory A; Irigoyen M; Gaynor B; Monhian R; Splaver A; Diamond B
    Ann N Y Acad Sci; 1995 Sep; 764():301-11. PubMed ID: 7486540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of the VH4-21 gene segment by anti-DNA antibodies from patients with systemic lupus erythematosus.
    Stevenson FK; Longhurst C; Chapman CJ; Ehrenstein M; Spellerberg MB; Hamblin TJ; Ravirajan CT; Latchman D; Isenberg D
    J Autoimmun; 1993 Dec; 6(6):809-25. PubMed ID: 8155258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The importance of the light chain for the epitope specificity of human anti-U1 small nuclear RNA autoantibodies present in systemic lupus erythematosus patients.
    Hoet RM; Pieffers M; Stassen MH; Raats J; de Wildt R; Pruijn GJ; van den Hoogen F; van Venrooij WJ
    J Immunol; 1999 Sep; 163(6):3304-12. PubMed ID: 10477600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The V(lambda)-J(lambda) repertoire of patients with systemic lupus erythematosus manifests characteristics of the natural antibody repertoire.
    Lee J; Cho YJ; Lipsky PE
    Arthritis Rheum; 2004 Aug; 50(8):2604-14. PubMed ID: 15334475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal analysis of a human antibody response. III. Nucleotide sequences of monoclonal IgM, IgG, and IgA to rabies virus reveal restricted V kappa gene utilization, junctional V kappa J kappa and V lambda J lambda diversity, and somatic hypermutation.
    Ikematsu W; Kobarg J; Ikematsu H; Ichiyoshi Y; Casali P
    J Immunol; 1998 Sep; 161(6):2895-905. PubMed ID: 9743351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-DNA-associated idiotype 8.12 is encoded by the V lambda II gene family and maps to the vicinity of L chain CDR1.
    Paul E; Iliev AA; Livneh A; Diamond B
    J Immunol; 1992 Dec; 149(11):3588-95. PubMed ID: 1431128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ig lambda and heavy chain gene usage in early untreated systemic lupus erythematosus suggests intensive B cell stimulation.
    Dörner T; Farner NL; Lipsky PE
    J Immunol; 1999 Jul; 163(2):1027-36. PubMed ID: 10395701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a germline Vk gene encoding cationic anti-DNA antibody and role of receptor editing for development of the autoantibody in patients with systemic lupus erythematosus.
    Suzuki N; Harada T; Mihara S; Sakane T
    J Clin Invest; 1996 Oct; 98(8):1843-50. PubMed ID: 8878436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. IV. The less frequently expressed VL are heterogeneous.
    Scott MG; Crimmins DL; McCourt DW; Chung G; Schäble KF; Thiebe R; Quenzel EM; Zachau HG; Nahm MH
    J Immunol; 1991 Dec; 147(11):4007-13. PubMed ID: 1940382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of the murine lupus-associated anti-self response: involvement of a large number of heavy and light chain variable region genes.
    Kofler R; Noonan DJ; Strohal R; Balderas RS; Møller NP; Dixon FJ; Theofilopoulos AN
    Eur J Immunol; 1987 Jan; 17(1):91-5. PubMed ID: 3102255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the human Ig V lambda II gene family and analysis of V lambda II and C lambda polymorphism in systemic lupus erythematosus.
    Paul E; Livneh A; Manheimer-Lory AJ; Diamond B
    J Immunol; 1991 Oct; 147(8):2771-6. PubMed ID: 1680918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The recurrent expression of variable region segments in human IgM anti-DNA autoantibodies.
    Dersimonian H; McAdam KP; Mackworth-Young C; Stollar BD
    J Immunol; 1989 Jun; 142(11):4027-33. PubMed ID: 2497186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence that the V kappa III gene usage is nonstochastic in both adult and newborn peripheral B cells and that peripheral CD5+ adult B cells are oligoclonal.
    Weber JC; Blaison G; Martin T; Knapp AM; Pasquali JL
    J Clin Invest; 1994 May; 93(5):2093-105. PubMed ID: 7514192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoantibody-encoding kappa L chain genes frequently rearranged in lambda L chain-expressing chronic lymphocytic leukemia.
    Rassenti LZ; Pratt LF; Chen PP; Carson DA; Kipps TJ
    J Immunol; 1991 Aug; 147(3):1060-6. PubMed ID: 1907304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B cell deletion, anergy, and receptor editing in "knock in" mice targeted with a germline-encoded or somatically mutated anti-DNA heavy chain.
    Pewzner-Jung Y; Friedmann D; Sonoda E; Jung S; Rajewsky K; Eilat D
    J Immunol; 1998 Nov; 161(9):4634-45. PubMed ID: 9794392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing the human antibody repertoire to exogenous antigens. Characterization of the H and L chain V region gene segments from anti-hepatitis B virus antibodies.
    Andris JS; Ehrlich PH; Ostberg L; Capra JD
    J Immunol; 1992 Dec; 149(12):4053-9. PubMed ID: 1460290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cloning and sequence analysis of the VH and VL regions of an anti-myelin/DNA antibody from a patient with peripheral neuropathy and chronic lymphocytic leukemia.
    Spatz LA; Wong KK; Williams M; Desai R; Golier J; Berman JE; Alt FW; Latov N
    J Immunol; 1990 Apr; 144(7):2821-8. PubMed ID: 2156935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usage of a novel class of germ-line Ig variable region gene for cationic anti-DNA autoantibodies in human lupus nephritis and its role for the development of the disease.
    Harada T; Suzuki N; Mizushima Y; Sakane T
    J Immunol; 1994 Nov; 153(10):4806-15. PubMed ID: 7963546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of V kappa families and V kappa exons. Implications for the available B cell repertoire.
    Kalled SL; Brodeur PH
    J Immunol; 1991 Nov; 147(9):3194-200. PubMed ID: 1919010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of the V kappa III-J kappa junctional diversity of polyclonal rheumatoid factors during rheumatoid arthritis frequently reveals N addition.
    Martin T; Blaison G; Levallois H; Pasquali JL
    Eur J Immunol; 1992 Jul; 22(7):1773-9. PubMed ID: 1339352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.